States are moving to curb copay accumulators as federal government pulls back from regulation.
John Linehan
Advertisement
Articles by John Linehan
Payers have used accumulators and maximizers to counteract drug coupons.
John S. Linehan of Epstein Becker & Green provides an in-depth analysis of drug coupons, coupon accumulators and maximizers and the federal government's halting efforts to regulate them.
Advertisement
Latest Updated Articles
New state copay accumulator laws complicate the coupon compliance landscapePublished: December 9th 2020 | Updated:
The Government Goes Back to the Future In Its Evolving Regulation of Drug Coupon Accumulator ProgramsPublished: June 17th 2020 | Updated:
Coupon Accumulators and Coupon Maximizers, ExplainedPublished: June 18th 2020 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Real-World Data Shows Vision Decline as Copay Programs Run Dry | AAO 2025
2
The Next Breakthrough in Schizophrenia Could be a Digital Therapeutic
3
In Complement Inhibition Debate, Game Change Goes Against Too Little, Too Late | AAO 2025
4
Biosimilars Gain Ground in Turkish Patients with RA and axSpA
5
